Immune Network

Papers
(The H4-Index of Immune Network is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Adenovirus Vectors: Excellent Tools for Vaccine Development56
Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy50
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene50
Targeted Immunotherapy for Autoimmune Disease44
SARS-CoV-2 Infection of Airway Epithelial Cells40
SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues39
Gut-Brain Connection: Microbiome, Gut Barrier, and Environmental Sensors38
Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages26
Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic21
Toll-like Receptor 2 in Autoimmune Inflammation19
Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation18
The Role of Upper Airway Microbiome in the Development of Adult Asthma18
Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation18
The Role of T Cells in Obesity-Associated Inflammation and Metabolic Disease13
Targeting the Epithelium-Derived Innate Cytokines: From Bench to Bedside13
Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control13
0.020347118377686